Gene · 6472
Papers2,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genotypic Variation of Nitrogen Use Efficiency and Amino Acid Metabolism in Barley. | Front Plant Sci | 2021 | 35185958 | PubTator, text mining | PubMed |
| Construction of five microRNAs prognostic markers and a prognostic model for clear cell renal cell carcinoma. | Transl Cancer Res | 2021 | 35116550 | PubTator, text mining | PubMed |
| Identification and Validation of Key Genes of Differential Correlations in Gastric Cancer. | Front Cell Dev Biol | 2021 | 35096829 | PubTator, text mining | PubMed |
| Folate Transport and One-Carbon Metabolism in Targeted Therapies of Epithelial Ovarian Cancer. | Cancers (Basel) | 2021 | 35008360 | PubTator, text mining | PubMed |
| Assessment of genetic polymorphism associated with ATP-binding cassette transporter A1 (ABCA1) gene and fluctuations in serum lipid profile levels in patients with coronary artery disease. | Saudi Pharm J | 2021 | 35002384 | PubTator, text mining | PubMed |
| [Catalytic mechanism, molecular engineering and applications of threonine aldolases]. | Sheng Wu Gong Cheng Xue Bao | 2021 | 34984869 | PubTator, text mining | PubMed |
| Construction of diagnostic and subtyping models for renal cell carcinoma by genome-wide DNA methylation profiles. | Transl Androl Urol | 2021 | 34984182 | PubTator, text mining | PubMed |
| One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies. | Epigenomes | 2021 | 34968247 | PubTator, text mining | PubMed |
| Nicotinamide adenine dinucleotide and the sirtuins caution: Pro-cancer functions. | Aging Med (Milton) | 2021 | 34964015 | PubTator, text mining | PubMed |
| Conjoint analysis of circulating tumor cells and solid tumors for exploring potential prognostic markers and constructing a robust novel predictive signature for breast cancer. | Cancer Cell Int | 2021 | 34953500 | PubTator, text mining | PubMed |
| Reduction of Rapid Proliferating Tumour Cell Lines by Inhibition of the Specific Glycine Transporter GLYT1. | Biomedicines | 2021 | 34944586 | PubTator, text mining | PubMed |
| The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer. | Front Cell Dev Biol | 2021 | 34938735 | PubTator, text mining | PubMed |
| Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. | Mol Cancer | 2021 | 34930302 | PubTator, text mining | PubMed |
| Targeting Mitochondrial Protein Expression as a Future Approach for Cancer Therapy. | Front Oncol | 2021 | 34888254 | PubTator, text mining | PubMed |
| Serum supplementation during bovine embryo culture affects their development and proliferation through macroautophagy and endoplasmic reticulum stress regulation. | PLoS One | 2021 | 34882691 | PubTator, text mining | PubMed |
| Acetylation in Tumor Immune Evasion Regulation. | Front Pharmacol | 2021 | 34880761 | PubTator, text mining | PubMed |
| Serine catabolism generates liver NADPH and supports hepatic lipogenesis. | Nat Metab | 2021 | 34845393 | PubTator, text mining | PubMed |
| The Dual Role of Circular RNAs as miRNA Sponges in Breast Cancer and Colon Cancer. | Biomedicines | 2021 | 34829818 | PubTator, text mining | PubMed |
| Mitochondrial Redox Metabolism: The Epicenter of Metabolism during Cancer Progression. | Antioxidants (Basel) | 2021 | 34829708 | PubTator, text mining | PubMed |
| CRIF1 Deficiency Increased Homocysteine Production by Disrupting Dihydrofolate Reductase Expression in Vascular Endothelial Cells. | Antioxidants (Basel) | 2021 | 34829516 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6472/papers?page=32